-+ 0.00%
-+ 0.00%
-+ 0.00%

REVOLUTION MEDICINES BEGINS TREATING PATIENTS IN PHASE 3 RASOLUTE 303 TRIAL EVALUATING DARAXONRASIB AS FIRST LINE TREATMENT FOR PATIENTS WITH METASTATIC PANCREATIC CANCER

Reuters·04/02/2026 12:00:03

Please log in to view news